Application | Comment | Organism |
---|---|---|
medicine | the DPP-4 inhibitor sitagliptin in diabetes therapy. Sitagliptin is effective, well tolerated and safe in clinical studies. Sitagliptin es effective in monotherapy and combination therapieswith metformin or glitazones. Sitagliptin does not show an increased incidence of hypoglycemic events | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
sitagliptin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
DPP-4 | - |
Homo sapiens |